Lana Louise Smith Keenan

USPTO Granted Patents = 14 (Patent Applications = 1)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 11 (Patent Applications = 12)

Average Co-Inventor Count = 9.6

ph-index = 3

Forward Citations = 27(Granted Patents)

Location History:

Ridgefield, CT (US) (2021)
Poughquag, NY (US) (2007 - 2023)

Company Filing History:

13 out of 1,537

Boehringer Ingelheim International Gmbh

patents

3 out of 49

Hydra Biosciences, Inc.

patents

1 out of 276

Boehringer Ingelheim Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2007-2023

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE49699 - Inhibitors of TRPC6 (2023-10-17),

2. 11485740 - Inhibitors of TRPC6 (2022-11-01),

3. 10954215 - Compounds as modulators of ROR gamma (2021-03-23),

4. 10889568 - Inhibitors of TRPC6 (2021-01-12),

5. 10800757 - Inhibitors of TRPC6 (2020-10-13),

6. 9573957 - Inhibitors of leukotriene production (2017-02-21),

7. 9403830 - Inhibitors of leukotriene production (2016-08-02),

8. 9133146 - Benzodioxane inhibitors of leukotriene production (2015-09-15),

9. 8859814 - [object Object] (2014-10-14),

10. 8785489 - Heteroaryl substituted indole compounds useful as MMP-13 inhibitors (2014-07-22),

11. 8637550 - Heteroaryl diamide compounds useful as MMP-13 inhibitors (2014-01-28),

12. 8586748 - 2-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10 (2013-11-19),

13. 8551982 - Benzodioxane inhibitors of leukotriene production (2013-10-08),

14. 7186827 - Dipeptide synthesis (2007-03-06),

Title: **Innovative Contributions of Lana Louise Smith Keenan**

Introduction

Lana Louise Smith Keenan is a notable inventor based in Poughquag, NY, recognized for her impactful contributions in the field of pharmaceuticals. With an impressive portfolio of 14 patents, her work has significantly advanced therapeutic options available for various diseases and disorders.

Latest Patents

Among her most recent innovations are her patents related to inhibitors of TRPC6. The first invention pertains to compounds of a specific formula, including pharmaceutically acceptable salts. This invention not only describes the compounds but also encompasses pharmaceutical compositions containing them, and the methods for utilizing these compounds in treating diverse medical conditions. The second patent similarly focuses on compounds of a related formula, extending the scope of her research in pharmaceutical applications.

Career Highlights

Lana has showcased her expertise while working for reputable companies such as Boehringer Ingelheim International GmbH and Hydra Biosciences, Inc. Her experience in these organizations played a vital role in her development as an inventor, enabling her to contribute to significant medical advancements.

Collaborations

Throughout her career, Lana has collaborated with talented colleagues, including Michael Robert Turner and Asitha Abeywardane. These partnerships have fostered a dynamic exchange of ideas and innovation, ultimately leading to the development of her groundbreaking patents.

Conclusion

Lana Louise Smith Keenan stands as a remarkable figure in the field of invention, using her talents to advance medical science through her innovative patents. Her ongoing contributions continue to inspire future advancements in pharmaceuticals, making her a key player in the industry.

This text is generated by artificial intelligence and may not be accurate.